 | • レポートコード：QYR2104Z2052 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、高度NSCLC用EGFR-TKIのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ゲフィチニブ、エルロチニブ、アファチニブ）、用途別市場規模（併用療法、免疫療法）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・高度NSCLC用EGFR-TKIの市場動向 ・企業の競争状況、市場シェア ・高度NSCLC用EGFR-TKIの種類別市場規模（ゲフィチニブ、エルロチニブ、アファチニブ） ・高度NSCLC用EGFR-TKIの用途別市場規模（併用療法、免疫療法） ・高度NSCLC用EGFR-TKIの北米市場規模2016-2027（アメリカ、カナダ） ・高度NSCLC用EGFR-TKIのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・高度NSCLC用EGFR-TKIのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・高度NSCLC用EGFR-TKIの中南米市場規模2016-2027（メキシコ、ブラジル） ・高度NSCLC用EGFR-TKIの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Henan DaKen Chemical、Capot Chemical Co.,Ltd.、Chemwill Asia Co.,Ltd.、MSN Labs、Sun Pharma、Amadis Chemical、Chongqing Chemdad Co., Ltd、Mylan、Alchem Pharmtech,Inc.） ・結論 |
EGFR tyrosine kinase inhibitors (TKIs) are molecules that could inhibt EGFR function through binding. Its monotherapy as first-line treatment can benefit NSCLC patients harbouring EGFR mutations.
Market Analysis and Insights: Global EGFR-TKI for Advanced NSCLC Market
The global EGFR-TKI for Advanced NSCLC market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global EGFR-TKI for Advanced NSCLC market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global EGFR-TKI for Advanced NSCLC market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global EGFR-TKI for Advanced NSCLC market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global EGFR-TKI for Advanced NSCLC market.
Global EGFR-TKI for Advanced NSCLC Scope and Market Size
EGFR-TKI for Advanced NSCLC market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global EGFR-TKI for Advanced NSCLC market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Gefitinib
Erlotinib
Afatinib
Segment by Application
Combination Therapy
Mono Therapy
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Henan DaKen Chemical
Capot Chemical Co.,Ltd.
Chemwill Asia Co.,Ltd.
MSN Labs
Sun Pharma
Amadis Chemical
Chongqing Chemdad Co., Ltd
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global EGFR-TKI for Advanced NSCLC Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Gefitinib
1.2.3 Erlotinib
1.2.4 Afatinib
1.3 Market by Application
1.3.1 Global EGFR-TKI for Advanced NSCLC Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Combination Therapy
1.3.3 Mono Therapy
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global EGFR-TKI for Advanced NSCLC Market Perspective (2016-2027)
2.2 EGFR-TKI for Advanced NSCLC Growth Trends by Regions
2.2.1 EGFR-TKI for Advanced NSCLC Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 EGFR-TKI for Advanced NSCLC Historic Market Share by Regions (2016-2021)
2.2.3 EGFR-TKI for Advanced NSCLC Forecasted Market Size by Regions (2022-2027)
2.3 EGFR-TKI for Advanced NSCLC Industry Dynamic
2.3.1 EGFR-TKI for Advanced NSCLC Market Trends
2.3.2 EGFR-TKI for Advanced NSCLC Market Drivers
2.3.3 EGFR-TKI for Advanced NSCLC Market Challenges
2.3.4 EGFR-TKI for Advanced NSCLC Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top EGFR-TKI for Advanced NSCLC Players by Revenue
3.1.1 Global Top EGFR-TKI for Advanced NSCLC Players by Revenue (2016-2021)
3.1.2 Global EGFR-TKI for Advanced NSCLC Revenue Market Share by Players (2016-2021)
3.2 Global EGFR-TKI for Advanced NSCLC Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by EGFR-TKI for Advanced NSCLC Revenue
3.4 Global EGFR-TKI for Advanced NSCLC Market Concentration Ratio
3.4.1 Global EGFR-TKI for Advanced NSCLC Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by EGFR-TKI for Advanced NSCLC Revenue in 2020
3.5 EGFR-TKI for Advanced NSCLC Key Players Head office and Area Served
3.6 Key Players EGFR-TKI for Advanced NSCLC Product Solution and Service
3.7 Date of Enter into EGFR-TKI for Advanced NSCLC Market
3.8 Mergers & Acquisitions, Expansion Plans
4 EGFR-TKI for Advanced NSCLC Breakdown Data by Type
4.1 Global EGFR-TKI for Advanced NSCLC Historic Market Size by Type (2016-2021)
4.2 Global EGFR-TKI for Advanced NSCLC Forecasted Market Size by Type (2022-2027)
5 EGFR-TKI for Advanced NSCLC Breakdown Data by Application
5.1 Global EGFR-TKI for Advanced NSCLC Historic Market Size by Application (2016-2021)
5.2 Global EGFR-TKI for Advanced NSCLC Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America EGFR-TKI for Advanced NSCLC Market Size (2016-2027)
6.2 North America EGFR-TKI for Advanced NSCLC Market Size by Type
6.2.1 North America EGFR-TKI for Advanced NSCLC Market Size by Type (2016-2021)
6.2.2 North America EGFR-TKI for Advanced NSCLC Market Size by Type (2022-2027)
6.2.3 North America EGFR-TKI for Advanced NSCLC Market Size by Type (2016-2027)
6.3 North America EGFR-TKI for Advanced NSCLC Market Size by Application
6.3.1 North America EGFR-TKI for Advanced NSCLC Market Size by Application (2016-2021)
6.3.2 North America EGFR-TKI for Advanced NSCLC Market Size by Application (2022-2027)
6.3.3 North America EGFR-TKI for Advanced NSCLC Market Size by Application (2016-2027)
6.4 North America EGFR-TKI for Advanced NSCLC Market Size by Country
6.4.1 North America EGFR-TKI for Advanced NSCLC Market Size by Country (2016-2021)
6.4.2 North America EGFR-TKI for Advanced NSCLC Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe EGFR-TKI for Advanced NSCLC Market Size (2016-2027)
7.2 Europe EGFR-TKI for Advanced NSCLC Market Size by Type
7.2.1 Europe EGFR-TKI for Advanced NSCLC Market Size by Type (2016-2021)
7.2.2 Europe EGFR-TKI for Advanced NSCLC Market Size by Type (2022-2027)
7.2.3 Europe EGFR-TKI for Advanced NSCLC Market Size by Type (2016-2027)
7.3 Europe EGFR-TKI for Advanced NSCLC Market Size by Application
7.3.1 Europe EGFR-TKI for Advanced NSCLC Market Size by Application (2016-2021)
7.3.2 Europe EGFR-TKI for Advanced NSCLC Market Size by Application (2022-2027)
7.3.3 Europe EGFR-TKI for Advanced NSCLC Market Size by Application (2016-2027)
7.4 Europe EGFR-TKI for Advanced NSCLC Market Size by Country
7.4.1 Europe EGFR-TKI for Advanced NSCLC Market Size by Country (2016-2021)
7.4.2 Europe EGFR-TKI for Advanced NSCLC Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific EGFR-TKI for Advanced NSCLC Market Size (2016-2027)
8.2 Asia-Pacific EGFR-TKI for Advanced NSCLC Market Size by Type
8.2.1 Asia-Pacific EGFR-TKI for Advanced NSCLC Market Size by Type (2016-2021)
8.2.2 Asia-Pacific EGFR-TKI for Advanced NSCLC Market Size by Type (2022-2027)
8.2.3 Asia-Pacific EGFR-TKI for Advanced NSCLC Market Size by Type (2016-2027)
8.3 Asia-Pacific EGFR-TKI for Advanced NSCLC Market Size by Application
8.3.1 Asia-Pacific EGFR-TKI for Advanced NSCLC Market Size by Application (2016-2021)
8.3.2 Asia-Pacific EGFR-TKI for Advanced NSCLC Market Size by Application (2022-2027)
8.3.3 Asia-Pacific EGFR-TKI for Advanced NSCLC Market Size by Application (2016-2027)
8.4 Asia-Pacific EGFR-TKI for Advanced NSCLC Market Size by Region
8.4.1 Asia-Pacific EGFR-TKI for Advanced NSCLC Market Size by Region (2016-2021)
8.4.2 Asia-Pacific EGFR-TKI for Advanced NSCLC Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America EGFR-TKI for Advanced NSCLC Market Size (2016-2027)
9.2 Latin America EGFR-TKI for Advanced NSCLC Market Size by Type
9.2.1 Latin America EGFR-TKI for Advanced NSCLC Market Size by Type (2016-2021)
9.2.2 Latin America EGFR-TKI for Advanced NSCLC Market Size by Type (2022-2027)
9.2.3 Latin America EGFR-TKI for Advanced NSCLC Market Size by Type (2016-2027)
9.3 Latin America EGFR-TKI for Advanced NSCLC Market Size by Application
9.3.1 Latin America EGFR-TKI for Advanced NSCLC Market Size by Application (2016-2021)
9.3.2 Latin America EGFR-TKI for Advanced NSCLC Market Size by Application (2022-2027)
9.3.3 Latin America EGFR-TKI for Advanced NSCLC Market Size by Application (2016-2027)
9.4 Latin America EGFR-TKI for Advanced NSCLC Market Size by Country
9.4.1 Latin America EGFR-TKI for Advanced NSCLC Market Size by Country (2016-2021)
9.4.2 Latin America EGFR-TKI for Advanced NSCLC Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa EGFR-TKI for Advanced NSCLC Market Size (2016-2027)
10.2 Middle East & Africa EGFR-TKI for Advanced NSCLC Market Size by Type
10.2.1 Middle East & Africa EGFR-TKI for Advanced NSCLC Market Size by Type (2016-2021)
10.2.2 Middle East & Africa EGFR-TKI for Advanced NSCLC Market Size by Type (2022-2027)
10.2.3 Middle East & Africa EGFR-TKI for Advanced NSCLC Market Size by Type (2016-2027)
10.3 Middle East & Africa EGFR-TKI for Advanced NSCLC Market Size by Application
10.3.1 Middle East & Africa EGFR-TKI for Advanced NSCLC Market Size by Application (2016-2021)
10.3.2 Middle East & Africa EGFR-TKI for Advanced NSCLC Market Size by Application (2022-2027)
10.3.3 Middle East & Africa EGFR-TKI for Advanced NSCLC Market Size by Application (2016-2027)
10.4 Middle East & Africa EGFR-TKI for Advanced NSCLC Market Size by Country
10.4.1 Middle East & Africa EGFR-TKI for Advanced NSCLC Market Size by Country (2016-2021)
10.4.2 Middle East & Africa EGFR-TKI for Advanced NSCLC Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Henan DaKen Chemical
11.1.1 Henan DaKen Chemical Company Details
11.1.2 Henan DaKen Chemical Business Overview
11.1.3 Henan DaKen Chemical EGFR-TKI for Advanced NSCLC Introduction
11.1.4 Henan DaKen Chemical Revenue in EGFR-TKI for Advanced NSCLC Business (2016-2021)
11.1.5 Henan DaKen Chemical Recent Development
11.2 Capot Chemical Co.,Ltd.
11.2.1 Capot Chemical Co.,Ltd. Company Details
11.2.2 Capot Chemical Co.,Ltd. Business Overview
11.2.3 Capot Chemical Co.,Ltd. EGFR-TKI for Advanced NSCLC Introduction
11.2.4 Capot Chemical Co.,Ltd. Revenue in EGFR-TKI for Advanced NSCLC Business (2016-2021)
11.2.5 Capot Chemical Co.,Ltd. Recent Development
11.3 Chemwill Asia Co.,Ltd.
11.3.1 Chemwill Asia Co.,Ltd. Company Details
11.3.2 Chemwill Asia Co.,Ltd. Business Overview
11.3.3 Chemwill Asia Co.,Ltd. EGFR-TKI for Advanced NSCLC Introduction
11.3.4 Chemwill Asia Co.,Ltd. Revenue in EGFR-TKI for Advanced NSCLC Business (2016-2021)
11.3.5 Chemwill Asia Co.,Ltd. Recent Development
11.4 MSN Labs
11.4.1 MSN Labs Company Details
11.4.2 MSN Labs Business Overview
11.4.3 MSN Labs EGFR-TKI for Advanced NSCLC Introduction
11.4.4 MSN Labs Revenue in EGFR-TKI for Advanced NSCLC Business (2016-2021)
11.4.5 MSN Labs Recent Development
11.5 Sun Pharma
11.5.1 Sun Pharma Company Details
11.5.2 Sun Pharma Business Overview
11.5.3 Sun Pharma EGFR-TKI for Advanced NSCLC Introduction
11.5.4 Sun Pharma Revenue in EGFR-TKI for Advanced NSCLC Business (2016-2021)
11.5.5 Sun Pharma Recent Development
11.6 Amadis Chemical
11.6.1 Amadis Chemical Company Details
11.6.2 Amadis Chemical Business Overview
11.6.3 Amadis Chemical EGFR-TKI for Advanced NSCLC Introduction
11.6.4 Amadis Chemical Revenue in EGFR-TKI for Advanced NSCLC Business (2016-2021)
11.6.5 Amadis Chemical Recent Development
11.7 Chongqing Chemdad Co., Ltd
11.7.1 Chongqing Chemdad Co., Ltd Company Details
11.7.2 Chongqing Chemdad Co., Ltd Business Overview
11.7.3 Chongqing Chemdad Co., Ltd EGFR-TKI for Advanced NSCLC Introduction
11.7.4 Chongqing Chemdad Co., Ltd Revenue in EGFR-TKI for Advanced NSCLC Business (2016-2021)
11.7.5 Chongqing Chemdad Co., Ltd Recent Development
11.8 Mylan
11.8.1 Mylan Company Details
11.8.2 Mylan Business Overview
11.8.3 Mylan EGFR-TKI for Advanced NSCLC Introduction
11.8.4 Mylan Revenue in EGFR-TKI for Advanced NSCLC Business (2016-2021)
11.8.5 Mylan Recent Development
11.9 Alchem Pharmtech,Inc.
11.9.1 Alchem Pharmtech,Inc. Company Details
11.9.2 Alchem Pharmtech,Inc. Business Overview
11.9.3 Alchem Pharmtech,Inc. EGFR-TKI for Advanced NSCLC Introduction
11.9.4 Alchem Pharmtech,Inc. Revenue in EGFR-TKI for Advanced NSCLC Business (2016-2021)
11.9.5 Alchem Pharmtech,Inc. Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global EGFR-TKI for Advanced NSCLC Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Gefitinib
Table 3. Key Players of Erlotinib
Table 4. Key Players of Afatinib
Table 5. Global EGFR-TKI for Advanced NSCLC Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global EGFR-TKI for Advanced NSCLC Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global EGFR-TKI for Advanced NSCLC Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global EGFR-TKI for Advanced NSCLC Market Share by Regions (2016-2021)
Table 9. Global EGFR-TKI for Advanced NSCLC Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global EGFR-TKI for Advanced NSCLC Market Share by Regions (2022-2027)
Table 11. EGFR-TKI for Advanced NSCLC Market Trends
Table 12. EGFR-TKI for Advanced NSCLC Market Drivers
Table 13. EGFR-TKI for Advanced NSCLC Market Challenges
Table 14. EGFR-TKI for Advanced NSCLC Market Restraints
Table 15. Global EGFR-TKI for Advanced NSCLC Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global EGFR-TKI for Advanced NSCLC Market Share by Players (2016-2021)
Table 17. Global Top EGFR-TKI for Advanced NSCLC Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in EGFR-TKI for Advanced NSCLC as of 2020)
Table 18. Ranking of Global Top EGFR-TKI for Advanced NSCLC Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by EGFR-TKI for Advanced NSCLC Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players EGFR-TKI for Advanced NSCLC Product Solution and Service
Table 22. Date of Enter into EGFR-TKI for Advanced NSCLC Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global EGFR-TKI for Advanced NSCLC Market Size by Type (2016-2021) (US$ Million)
Table 25. Global EGFR-TKI for Advanced NSCLC Revenue Market Share by Type (2016-2021)
Table 26. Global EGFR-TKI for Advanced NSCLC Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global EGFR-TKI for Advanced NSCLC Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global EGFR-TKI for Advanced NSCLC Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global EGFR-TKI for Advanced NSCLC Revenue Market Share by Application (2016-2021)
Table 30. Global EGFR-TKI for Advanced NSCLC Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global EGFR-TKI for Advanced NSCLC Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America EGFR-TKI for Advanced NSCLC Market Size by Type (2016-2021) (US$ Million)
Table 33. North America EGFR-TKI for Advanced NSCLC Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America EGFR-TKI for Advanced NSCLC Market Size by Application (2016-2021) (US$ Million)
Table 35. North America EGFR-TKI for Advanced NSCLC Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America EGFR-TKI for Advanced NSCLC Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America EGFR-TKI for Advanced NSCLC Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe EGFR-TKI for Advanced NSCLC Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe EGFR-TKI for Advanced NSCLC Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe EGFR-TKI for Advanced NSCLC Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe EGFR-TKI for Advanced NSCLC Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe EGFR-TKI for Advanced NSCLC Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe EGFR-TKI for Advanced NSCLC Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific EGFR-TKI for Advanced NSCLC Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific EGFR-TKI for Advanced NSCLC Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific EGFR-TKI for Advanced NSCLC Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific EGFR-TKI for Advanced NSCLC Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific EGFR-TKI for Advanced NSCLC Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific EGFR-TKI for Advanced NSCLC Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America EGFR-TKI for Advanced NSCLC Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America EGFR-TKI for Advanced NSCLC Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America EGFR-TKI for Advanced NSCLC Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America EGFR-TKI for Advanced NSCLC Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America EGFR-TKI for Advanced NSCLC Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America EGFR-TKI for Advanced NSCLC Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa EGFR-TKI for Advanced NSCLC Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa EGFR-TKI for Advanced NSCLC Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa EGFR-TKI for Advanced NSCLC Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa EGFR-TKI for Advanced NSCLC Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa EGFR-TKI for Advanced NSCLC Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa EGFR-TKI for Advanced NSCLC Market Size by Country (2022-2027) & (US$ Million)
Table 62. Henan DaKen Chemical Company Details
Table 63. Henan DaKen Chemical Business Overview
Table 64. Henan DaKen Chemical EGFR-TKI for Advanced NSCLC Product
Table 65. Henan DaKen Chemical Revenue in EGFR-TKI for Advanced NSCLC Business (2016-2021) & (US$ Million)
Table 66. Henan DaKen Chemical Recent Development
Table 67. Capot Chemical Co.,Ltd. Company Details
Table 68. Capot Chemical Co.,Ltd. Business Overview
Table 69. Capot Chemical Co.,Ltd. EGFR-TKI for Advanced NSCLC Product
Table 70. Capot Chemical Co.,Ltd. Revenue in EGFR-TKI for Advanced NSCLC Business (2016-2021) & (US$ Million)
Table 71. Capot Chemical Co.,Ltd. Recent Development
Table 72. Chemwill Asia Co.,Ltd. Company Details
Table 73. Chemwill Asia Co.,Ltd. Business Overview
Table 74. Chemwill Asia Co.,Ltd. EGFR-TKI for Advanced NSCLC Product
Table 75. Chemwill Asia Co.,Ltd. Revenue in EGFR-TKI for Advanced NSCLC Business (2016-2021) & (US$ Million)
Table 76. Chemwill Asia Co.,Ltd. Recent Development
Table 77. MSN Labs Company Details
Table 78. MSN Labs Business Overview
Table 79. MSN Labs EGFR-TKI for Advanced NSCLC Product
Table 80. MSN Labs Revenue in EGFR-TKI for Advanced NSCLC Business (2016-2021) & (US$ Million)
Table 81. MSN Labs Recent Development
Table 82. Sun Pharma Company Details
Table 83. Sun Pharma Business Overview
Table 84. Sun Pharma EGFR-TKI for Advanced NSCLC Product
Table 85. Sun Pharma Revenue in EGFR-TKI for Advanced NSCLC Business (2016-2021) & (US$ Million)
Table 86. Sun Pharma Recent Development
Table 87. Amadis Chemical Company Details
Table 88. Amadis Chemical Business Overview
Table 89. Amadis Chemical EGFR-TKI for Advanced NSCLC Product
Table 90. Amadis Chemical Revenue in EGFR-TKI for Advanced NSCLC Business (2016-2021) & (US$ Million)
Table 91. Amadis Chemical Recent Development
Table 92. Chongqing Chemdad Co., Ltd Company Details
Table 93. Chongqing Chemdad Co., Ltd Business Overview
Table 94. Chongqing Chemdad Co., Ltd EGFR-TKI for Advanced NSCLC Product
Table 95. Chongqing Chemdad Co., Ltd Revenue in EGFR-TKI for Advanced NSCLC Business (2016-2021) & (US$ Million)
Table 96. Chongqing Chemdad Co., Ltd Recent Development
Table 97. Mylan Company Details
Table 98. Mylan Business Overview
Table 99. Mylan Revenue in EGFR-TKI for Advanced NSCLC Business (2016-2021) & (US$ Million)
Table 100. Mylan Recent Development
Table 101. Alchem Pharmtech,Inc. Company Details
Table 102. Alchem Pharmtech,Inc. Business Overview
Table 103. Alchem Pharmtech,Inc. EGFR-TKI for Advanced NSCLC Product
Table 104. Alchem Pharmtech,Inc. Revenue in EGFR-TKI for Advanced NSCLC Business (2016-2021) & (US$ Million)
Table 105. Alchem Pharmtech,Inc. Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global EGFR-TKI for Advanced NSCLC Market Share by Type: 2020 VS 2027
Figure 2. Gefitinib Features
Figure 3. Erlotinib Features
Figure 4. Afatinib Features
Figure 5. Global EGFR-TKI for Advanced NSCLC Market Share by Application: 2020 VS 2027
Figure 6. Combination Therapy Case Studies
Figure 7. Mono Therapy Case Studies
Figure 8. EGFR-TKI for Advanced NSCLC Report Years Considered
Figure 9. Global EGFR-TKI for Advanced NSCLC Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global EGFR-TKI for Advanced NSCLC Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global EGFR-TKI for Advanced NSCLC Market Share by Regions: 2020 VS 2027
Figure 12. Global EGFR-TKI for Advanced NSCLC Market Share by Regions (2022-2027)
Figure 13. Global EGFR-TKI for Advanced NSCLC Market Share by Players in 2020
Figure 14. Global Top EGFR-TKI for Advanced NSCLC Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in EGFR-TKI for Advanced NSCLC as of 2020
Figure 15. The Top 10 and 5 Players Market Share by EGFR-TKI for Advanced NSCLC Revenue in 2020
Figure 16. Global EGFR-TKI for Advanced NSCLC Revenue Market Share by Type (2016-2021)
Figure 17. Global EGFR-TKI for Advanced NSCLC Revenue Market Share by Type (2022-2027)
Figure 18. North America EGFR-TKI for Advanced NSCLC Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America EGFR-TKI for Advanced NSCLC Market Share by Type (2016-2027)
Figure 20. North America EGFR-TKI for Advanced NSCLC Market Share by Application (2016-2027)
Figure 21. North America EGFR-TKI for Advanced NSCLC Market Share by Country (2016-2027)
Figure 22. United States EGFR-TKI for Advanced NSCLC Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada EGFR-TKI for Advanced NSCLC Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe EGFR-TKI for Advanced NSCLC Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe EGFR-TKI for Advanced NSCLC Market Share by Type (2016-2027)
Figure 26. Europe EGFR-TKI for Advanced NSCLC Market Share by Application (2016-2027)
Figure 27. Europe EGFR-TKI for Advanced NSCLC Market Share by Country (2016-2027)
Figure 28. Germany EGFR-TKI for Advanced NSCLC Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France EGFR-TKI for Advanced NSCLC Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. EGFR-TKI for Advanced NSCLC Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy EGFR-TKI for Advanced NSCLC Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia EGFR-TKI for Advanced NSCLC Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic EGFR-TKI for Advanced NSCLC Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific EGFR-TKI for Advanced NSCLC Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific EGFR-TKI for Advanced NSCLC Market Share by Type (2016-2027)
Figure 36. Asia-Pacific EGFR-TKI for Advanced NSCLC Market Share by Application (2016-2027)
Figure 37. Asia-Pacific EGFR-TKI for Advanced NSCLC Market Share by Region (2016-2027)
Figure 38. China EGFR-TKI for Advanced NSCLC Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan EGFR-TKI for Advanced NSCLC Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea EGFR-TKI for Advanced NSCLC Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia EGFR-TKI for Advanced NSCLC Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India EGFR-TKI for Advanced NSCLC Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia EGFR-TKI for Advanced NSCLC Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America EGFR-TKI for Advanced NSCLC Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America EGFR-TKI for Advanced NSCLC Market Share by Type (2016-2027)
Figure 46. Latin America EGFR-TKI for Advanced NSCLC Market Share by Application (2016-2027)
Figure 47. Latin America EGFR-TKI for Advanced NSCLC Market Share by Country (2016-2027)
Figure 48. Mexico EGFR-TKI for Advanced NSCLC Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil EGFR-TKI for Advanced NSCLC Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa EGFR-TKI for Advanced NSCLC Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa EGFR-TKI for Advanced NSCLC Market Share by Type (2016-2027)
Figure 52. Middle East & Africa EGFR-TKI for Advanced NSCLC Market Share by Application (2016-2027)
Figure 53. Middle East & Africa EGFR-TKI for Advanced NSCLC Market Share by Country (2016-2027)
Figure 54. Turkey EGFR-TKI for Advanced NSCLC Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia EGFR-TKI for Advanced NSCLC Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE EGFR-TKI for Advanced NSCLC Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Henan DaKen Chemical Revenue Growth Rate in EGFR-TKI for Advanced NSCLC Business (2016-2021)
Figure 58. Capot Chemical Co.,Ltd. Revenue Growth Rate in EGFR-TKI for Advanced NSCLC Business (2016-2021)
Figure 59. Chemwill Asia Co.,Ltd. Revenue Growth Rate in EGFR-TKI for Advanced NSCLC Business (2016-2021)
Figure 60. MSN Labs Revenue Growth Rate in EGFR-TKI for Advanced NSCLC Business (2016-2021)
Figure 61. Sun Pharma Revenue Growth Rate in EGFR-TKI for Advanced NSCLC Business (2016-2021)
Figure 62. Amadis Chemical Revenue Growth Rate in EGFR-TKI for Advanced NSCLC Business (2016-2021)
Figure 63. Chongqing Chemdad Co., Ltd Revenue Growth Rate in EGFR-TKI for Advanced NSCLC Business (2016-2021)
Figure 64. Mylan Revenue Growth Rate in EGFR-TKI for Advanced NSCLC Business (2016-2021)
Figure 65. Alchem Pharmtech,Inc. Revenue Growth Rate in EGFR-TKI for Advanced NSCLC Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
世界の高度NSCLC用EGFR-TKI市場規模・現状・予測（2021年-2027年） EGFR tyrosine kinase inhibitors (TKIs) are molecules that could inhibt EGFR function through binding. Its monotherapy as first-line treatment can benefit NSCLC patients harbouring EGFR mutations. Market Analysis and Insights: Global EGFR-TKI for Advanced NSCLC Market The global EGFR-TKI for Advanced…- 世界のNSCLC治療薬市場規模・現状・予測（2021年-2027年） Some cancer cells have gene changes (also called mutations) that help them grow and spread. The NSCLC Drugs is to block those changes. Market Analysis and Insights: Global NSCLC Drugs Market The global NSCLC Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020,…
- 世界のEGFR変異試験市場規模・現状・予測（2021年-2027年） Epidermal growth factor receptor (EGFR) is a type of protein, which is located on the surface of human body cells. Any mutation in EGFR gene can lead to various types of cancer. EGFR functions as a biomarker for non-small cell lung cancer (NSCLC) and due to the mutation of EGFR gene a person may suf…
- 世界のHER2陽性進行性乳がん用モノクローナル抗体（mAb）市場規模・現状・予測（2021年-2027年） These antibodies are used to treat metastatic (spread) breast cancer. It is effective against tumors that overexpress the HER2/neu protein. Market Analysis and Insights: Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market The global Mono-Antibody (mAb) for HER2-Positive Advanc…
- 世界のがん幹細胞（CSC）治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cancer Stem Cell Therapy Market The global Cancer Stem Cell Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the …